shortagewatch

Home / Cardiovascular system / Procainamide

ATC C01BA02 · Antiarrhythmics, Class Ia

Procainamide shortage

As of 2 Nov 2026, Procainamide has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 8 products from 3 companies.

Countries2/15
Products8packs or presentations
Companies30 listed
Short since17 Sep 201313.1 years ago
Earliest returnnot givencompany estimate
Main reasonOther
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan4 products shortAustraliaNo reported shortage

Timeline

CanadaJapan
20222023202420252026PROCAN SR (bottle of 100)PROCAN SR (bottle of 100)APO-PROCAINAMIDE CAP 250MG (100 BTL)APO-PROCAINAMIDE CAP 250MG (100 BTL)APO-PROCAINAMIDE CAP 375MG (100 BTL)APO-PROCAINAMIDE CAP 375MG (100 BTL)APO-PROCAINAMIDE CAP 500MG (100 BTL)APO-PROCAINAMIDE CAP 500MG (100 BTL)アミサリン錠125mgアミサリン錠125mgアミサリン錠250mgアミサリン錠250mgアミサリン注100mgアミサリン注100mgアミサリン注200mgアミサリン注200mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Alfresa Pharma4Apotex3Erfa 20121

Compared with similar medicines

ATC group C01BA · Antiarrhythmics, Class Ia
Ajmaline3/15Disopyramide2/15Procainamide2/15

Affected products

CountryProductCompanySinceExpected backReason
CAPROCAN SR (bottle of 100) discontinuationERFA CANADA 2012 INC17 Sep 2013not givenOther
Other (Please describe in comments)
CAAPO-PROCAINAMIDE CAP 250MG (100 BTL)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-PROCAINAMIDE CAP 375MG (100 BTL)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-PROCAINAMIDE CAP 500MG (100 BTL)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
アミサリン錠125mgアルフレッサファーマ16 Apr 2025not givenActive ingredient shortage
Raw material (active ingredient) supply problem
アミサリン錠250mgアルフレッサファーマ16 Apr 2025not givenActive ingredient shortage
Raw material (active ingredient) supply problem
アミサリン注100mg limitedアルフレッサファーマ22 Jan 2026not givenOther
アミサリン注200mg limitedアルフレッサファーマ22 Jan 2026not givenOther

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.